Rentokil Initial (LON:RTO – Get Free Report)‘s stock had its “sell” rating reiterated by investment analysts at Berenberg Bank in a research report issued to clients and investors on Monday,Digital Look reports. They currently have a GBX 284 price target on the stock. Berenberg Bank’s target price would indicate a potential downside of 24.57% from the company’s current price.
Other equities analysts have also recently issued reports about the company. JPMorgan Chase & Co. reaffirmed a “no recommendation” rating on shares of Rentokil Initial in a report on Monday, August 11th. Deutsche Bank Aktiengesellschaft raised their target price on Rentokil Initial from GBX 425 to GBX 435 and gave the stock a “buy” rating in a report on Monday, July 21st. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 440 target price on shares of Rentokil Initial in a report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of GBX 397.25.
View Our Latest Report on Rentokil Initial
Rentokil Initial Price Performance
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Articles
- Five stocks we like better than Rentokil Initial
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- NYSE Stocks Give Investors a Variety of Quality Options
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- What is the Nikkei 225 index?
- This ETF Weeds Out Small-Cap Underperformers
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.